Scienture Holdings, Inc. (SCNX)

Scienture Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	7.45	8.27	10.25
Revenue Growth (YoY)	-	-19.30%	-
Cost of Revenue	7.87	8.37	8.31
Gross Profit	-0.42	-0.1	1.94
Selling, General & Admin	10.99	5.79	3.86
Research & Development	1.46	1.38	0.99
Operating Expenses	12.45	7.16	4.85
Operating Income	-12.87	-7.26	-2.92
Interest Expense	-1.06	-1.2	-0.34
Interest & Investment Income	0.1	0	0.02
Other Non Operating Income (Expenses)	0.34	-0.13	0.83
EBT Excluding Unusual Items	-13.49	-8.59	-2.41
Impairment of Goodwill	-5.13	-5.13	-
Gain (Loss) on Sale of Assets	-0.02	-	0
Pretax Income	-18.64	-13.72	-2.4
Earnings From Continuing Operations	-18.64	-13.72	-2.4
Earnings From Discontinued Operations	22.86	-4.12	-1.51
Net Income to Company	4.22	-17.84	-3.91
Minority Interest in Earnings	-	-	0.44
Net Income	4.22	-17.84	-3.47
Net Income to Common	4.22	-17.84	-3.47
Shares Outstanding (Basic)	1	1	1
Shares Outstanding (Diluted)	1	1	1
Shares Change (YoY)	-	35.26%	-
EPS (Basic)	4.06	-23.35	-6.15
EPS (Diluted)	4.06	-23.35	-6.15
Free Cash Flow	-7.44	-2.07	-1.56
Free Cash Flow Per Share	-7.16	-2.71	-2.77
Gross Margin	-5.65%	-1.21%	18.91%
Operating Margin	-172.81%	-87.80%	-28.45%
Profit Margin	56.68%	-215.70%	-33.87%
Free Cash Flow Margin	-99.87%	-25.07%	-15.26%
EBITDA	-12.04	-6.43	-2.9
EBITDA Margin	-161.67%	-77.72%	-28.32%
D&A For EBITDA	0.83	0.83	0.01
EBIT	-12.87	-7.26	-2.92
EBIT Margin	-172.81%	-87.80%	-28.45%

Source: S&P Capital IQ. Standard template. Financial Sources.